In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
This second pre-release edition of GBR's PERUMIN 2023 Official Investment Guide comprises an analysis based on more than 70 interviews with the leading executives from the entire mining value chain of the Peruvian mining industry to provide a holistic view of the events taking place in the country, how those events have impacted their activities, and what they expect for the upcoming months.
GENERAL MANAGER, SNF FLOERGER
"In 2023, we anticipate growing our market reach by double-digits and developing new products, which will be largely driven by the expansion of the Mexican market, as well as our focus on bolstering the paper, mining, and agriculture sector through the use of our products."